EMA’s response to articlesBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3838 (Published 20 June 2011) Cite this as: BMJ 2011;342:d3838
- Andreas Pott, acting executive director1
- 1European Medicines Agency, London E14 4HB, UK
Two recent BMJ articles have given the European Medicines Agency (EMA) useful feedback from the academic community on its provision of information on the scientific review of medicines.1 2 The agency is grateful for and open to suggestions on how this can be improved.
The authors of both articles ignore recent steps that the agency has taken to improve the transparency …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial